Sociodemographic variables associated with risk for diabetic retinopathy
- PMID: 36280885
- PMCID: PMC9590219
- DOI: 10.1186/s40842-022-00144-z
Sociodemographic variables associated with risk for diabetic retinopathy
Abstract
Background: Several systemic and sociodemographic factors have been associated with the development and progression of diabetic retinopathy (DR). However, there is limited investigation of the potential role sociodemographic factors may play in augmenting systemic risk factors of DR. We hypothesize that age, sex, race, ethnicity, income, and insurance payor have an impact on hemoglobin A1c (HbA1c), body mass index, and systolic blood pressure, and therefore an upstream effect on the development of DR and vision-threatening forms of DR (VTDR).
Methods: Multivariable analysis of longitudinal electronic health record data at a large academic retina clinic was performed. Sociodemographic factors included race, ethnicity, income, and insurance payor. Systemic risk factors for DR included hemoglobin A1c (HbA1c), systolic blood pressure (SBP), and body mass index (BMI). VTDR was identified from encounter diagnostic codes indicating proliferative retinopathy or diabetic macular edema. Patient-reported primary address zip codes were used to approximate income level, stratified into quartiles.
Results: From 2016 to 2018, 3,470 patients with diabetes totaled 11,437 visits were identified. Black patients had higher HbA1c and SBP compared to White patients. White patients had higher BMI and SBP compared to patients of unknown/other race and greater odds of VTDR than the latter. Patients of Hispanic ethnicity had significantly higher SBP than non-Hispanic patients. Low-income patients had higher BMI and SBP than high-income patients and greater odds of VTDR than the latter. Medicaid recipients had greater odds of VTDR than those with Blue Care Network (BCN) and Blue Cross Blue Shield (BCBS) insurance. Medicaid and Medicare recipients had higher SBP compared to BCBS recipients. Finally, both higher HbA1c and SBP had greater odds of VTDR. There were no differences in odds of VTDR between White and Black patients or between Hispanic and non-Hispanic patients.
Conclusion: Significant associations exist between certain sociodemographic factors and well-known risk factors for DR. Income and payor were associated with increased severity of systemic risk factors and presence of VTDR. These results warrant further investigation of how risk factor optimization and disease prevention may be further improved by targeted intervention of these modifiable sociodemographic factors.
Keywords: Diabetic retinopathy; Health disparities; Health outcomes; Risk factors.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus.Acta Ophthalmol. 2018 Aug;96(5):459-464. doi: 10.1111/aos.13815. Acta Ophthalmol. 2018. PMID: 30188024 Free PMC article.
-
Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic Retinopathy.JAMA Ophthalmol. 2022 May 1;140(5):529-532. doi: 10.1001/jamaophthalmol.2022.0633. JAMA Ophthalmol. 2022. PMID: 35389455 Free PMC article.
-
Factors Associated with Prevalent Diabetic Retinopathy in Chinese Americans: The Chinese American Eye Study.Ophthalmol Retina. 2018 Feb;2(2):96-105. doi: 10.1016/j.oret.2017.05.014. Epub 2017 Aug 16. Ophthalmol Retina. 2018. PMID: 29503969 Free PMC article.
-
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2. Cochrane Database Syst Rev. 2023. PMID: 36815723 Free PMC article. Review.
-
The relationship between refractive error and the risk of diabetic retinopathy: a systematic review and meta-analysis.Front Med (Lausanne). 2024 Jun 4;11:1354856. doi: 10.3389/fmed.2024.1354856. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38895184 Free PMC article.
Cited by
-
Predictors of Vision Loss After Lapse in Antivascular Endothelial Growth Factor Treatment in Patients With Diabetic Macular Edema.J Vitreoretin Dis. 2024 Dec 13:24741264241305123. doi: 10.1177/24741264241305123. Online ahead of print. J Vitreoretin Dis. 2024. PMID: 39678936 Free PMC article.
-
An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective.Eye (Lond). 2024 Jul;38(10):1917-1925. doi: 10.1038/s41433-024-03043-y. Epub 2024 Mar 30. Eye (Lond). 2024. PMID: 38555401 Free PMC article.
-
The Relationship Between Health Insurance Status and Diabetic Retinopathy Progression.Ophthalmol Sci. 2023 Dec 22;4(3):100458. doi: 10.1016/j.xops.2023.100458. eCollection 2024 May-Jun. Ophthalmol Sci. 2023. PMID: 38317868 Free PMC article.
-
Demographic and Metabolic Risk Factors Associated with Development of Diabetic Macular Edema among Persons with Diabetes Mellitus.Ophthalmol Sci. 2024 May 23;4(6):100557. doi: 10.1016/j.xops.2024.100557. eCollection 2024 Nov-Dec. Ophthalmol Sci. 2024. PMID: 39149711 Free PMC article.
-
Diabetes-Related Microvascular Complications in Primary Health Care Settings in the West Bank, Palestine.J Clin Med. 2023 Oct 24;12(21):6719. doi: 10.3390/jcm12216719. J Clin Med. 2023. PMID: 37959185 Free PMC article.
References
LinkOut - more resources
Full Text Sources